Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(3.74)
# 763
Out of 5,124 analysts
468
Total ratings
43.76%
Success rate
10.02%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EKSO Ekso Bionics Holdings | Downgrades: Neutral | n/a | $8.64 | - | 17 | Dec 31, 2025 | |
| PYXS Pyxis Oncology | Maintains: Buy | $5 → $7 | $1.15 | +508.70% | 11 | Dec 19, 2025 | |
| ABSI Absci | Maintains: Buy | $7 → $8 | $3.49 | +129.23% | 15 | Dec 18, 2025 | |
| JANX Janux Therapeutics | Maintains: Buy | $70 → $45 | $13.80 | +226.09% | 14 | Dec 2, 2025 | |
| CORT Corcept Therapeutics | Reiterates: Buy | $145 | $34.80 | +316.67% | 25 | Nov 25, 2025 | |
| MDWD MediWound | Maintains: Buy | $31 → $36 | $18.46 | +95.02% | 20 | Nov 21, 2025 | |
| ACTU Actuate Therapeutics | Reiterates: Buy | $20 | $6.12 | +226.80% | 4 | Nov 19, 2025 | |
| LFWD Lifeward | Maintains: Buy | $13 → $4.5 | $0.58 | +680.44% | 8 | Nov 18, 2025 | |
| NUVL Nuvalent | Maintains: Buy | $130 → $155 | $100.59 | +54.09% | 5 | Nov 17, 2025 | |
| CELC Celcuity | Downgrades: Neutral | $77 → $94 | $99.74 | -5.75% | 11 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8.5 → $9 | $4.18 | +115.31% | 14 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $55 → $32 | $13.08 | +144.65% | 16 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $7.96 | +63.32% | 19 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $47 | $41.21 | +14.05% | 8 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $5 | $4.00 | +25.00% | 18 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $81 | $78.99 | +2.54% | 3 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $2.5 | $0.20 | +1,150.00% | 1 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $5 | $1.78 | +180.90% | 18 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $22 | $5.77 | +281.28% | 2 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $3 | $0.94 | +219.15% | 1 | Oct 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $30 | $10.10 | +197.03% | 15 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $4.77 | +235.43% | 14 | Oct 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $1.40 | +685.71% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $15 | $2.70 | +455.56% | 2 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $0.96 | +212.34% | 2 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.35 | +418.52% | 22 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $35 | $16.91 | +106.98% | 8 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | n/a | $1.10 | - | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $0.84 | +257.10% | 3 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $1.13 | +76.99% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.42 | +146.48% | 4 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $3.29 | +477.51% | 14 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $180 | $2.34 | +7,592.31% | 15 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.49 | +457.41% | 13 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $36.01 | +66.62% | 18 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $7.05 | +368.09% | 18 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.41 | +1,118.92% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.77 | +62.48% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $6.59 | +203.49% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.64 | +59.57% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.23 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.63 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.11 | +2,152.25% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.89 | +164.55% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $90 → $120 | $2.88 | +4,066.67% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $0.85 | +1,311.76% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.57 | +3,422.99% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $13.73 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $7.70 | -22.08% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $1.56 | +861.54% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $7.72 | +327.46% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $21.04 | -54.85% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $1.03 | +1,359,123.30% | 1 | Mar 5, 2020 |
Ekso Bionics Holdings
Dec 31, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.64
Upside: -
Pyxis Oncology
Dec 19, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $1.15
Upside: +508.70%
Absci
Dec 18, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $3.49
Upside: +129.23%
Janux Therapeutics
Dec 2, 2025
Maintains: Buy
Price Target: $70 → $45
Current: $13.80
Upside: +226.09%
Corcept Therapeutics
Nov 25, 2025
Reiterates: Buy
Price Target: $145
Current: $34.80
Upside: +316.67%
MediWound
Nov 21, 2025
Maintains: Buy
Price Target: $31 → $36
Current: $18.46
Upside: +95.02%
Actuate Therapeutics
Nov 19, 2025
Reiterates: Buy
Price Target: $20
Current: $6.12
Upside: +226.80%
Lifeward
Nov 18, 2025
Maintains: Buy
Price Target: $13 → $4.5
Current: $0.58
Upside: +680.44%
Nuvalent
Nov 17, 2025
Maintains: Buy
Price Target: $130 → $155
Current: $100.59
Upside: +54.09%
Celcuity
Nov 17, 2025
Downgrades: Neutral
Price Target: $77 → $94
Current: $99.74
Upside: -5.75%
Nov 14, 2025
Maintains: Buy
Price Target: $8.5 → $9
Current: $4.18
Upside: +115.31%
Nov 14, 2025
Maintains: Buy
Price Target: $55 → $32
Current: $13.08
Upside: +144.65%
Nov 11, 2025
Maintains: Buy
Price Target: $10 → $13
Current: $7.96
Upside: +63.32%
Nov 10, 2025
Maintains: Buy
Price Target: $40 → $47
Current: $41.21
Upside: +14.05%
Nov 10, 2025
Maintains: Buy
Price Target: $3.5 → $5
Current: $4.00
Upside: +25.00%
Nov 5, 2025
Maintains: Buy
Price Target: $80 → $81
Current: $78.99
Upside: +2.54%
Nov 4, 2025
Assumes: Buy
Price Target: $2.5
Current: $0.20
Upside: +1,150.00%
Oct 29, 2025
Upgrades: Buy
Price Target: $5
Current: $1.78
Upside: +180.90%
Oct 29, 2025
Maintains: Buy
Price Target: $9 → $22
Current: $5.77
Upside: +281.28%
Oct 23, 2025
Assumes: Buy
Price Target: $3
Current: $0.94
Upside: +219.15%
Oct 20, 2025
Maintains: Buy
Price Target: $31 → $30
Current: $10.10
Upside: +197.03%
Oct 20, 2025
Reiterates: Buy
Price Target: $16
Current: $4.77
Upside: +235.43%
Aug 21, 2025
Reiterates: Buy
Price Target: $11
Current: $1.40
Upside: +685.71%
Aug 14, 2025
Reiterates: Neutral
Price Target: $15
Current: $2.70
Upside: +455.56%
Aug 12, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $0.96
Upside: +212.34%
Jun 24, 2025
Reiterates: Buy
Price Target: $7
Current: $1.35
Upside: +418.52%
May 29, 2025
Maintains: Buy
Price Target: $33 → $35
Current: $16.91
Upside: +106.98%
May 19, 2025
Reiterates: Buy
Price Target: n/a
Current: $1.10
Upside: -
May 19, 2025
Reiterates: Buy
Price Target: $3
Current: $0.84
Upside: +257.10%
May 9, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $1.13
Upside: +76.99%
Apr 2, 2025
Reiterates: Buy
Price Target: $3.5
Current: $1.42
Upside: +146.48%
Mar 28, 2025
Reiterates: Buy
Price Target: $19
Current: $3.29
Upside: +477.51%
Mar 14, 2025
Maintains: Buy
Price Target: $240 → $180
Current: $2.34
Upside: +7,592.31%
Mar 13, 2025
Reiterates: Buy
Price Target: $25
Current: $4.49
Upside: +457.41%
Feb 28, 2025
Reiterates: Buy
Price Target: $60
Current: $36.01
Upside: +66.62%
Feb 26, 2025
Reiterates: Buy
Price Target: $33
Current: $7.05
Upside: +368.09%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $0.41
Upside: +1,118.92%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $6.77
Upside: +62.48%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $6.59
Upside: +203.49%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.64
Upside: +59.57%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $3.23
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.63
Upside: -
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.11
Upside: +2,152.25%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $1.89
Upside: +164.55%
Nov 4, 2022
Maintains: Buy
Price Target: $90 → $120
Current: $2.88
Upside: +4,066.67%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $0.85
Upside: +1,311.76%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.57
Upside: +3,422.99%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $13.73
Upside: -
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $7.70
Upside: -22.08%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $1.56
Upside: +861.54%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $7.72
Upside: +327.46%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $21.04
Upside: -54.85%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $1.03
Upside: +1,359,123.30%